PCV2 Comparative Efficacy and Safety Analysis of Atrial Fibrillaion Patients Treated with Dabigatran in RE-LY Study (CHADS 2 Score of 3 or Greater ) Versus Rivaroxaban in ROCKET-AF
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.945
https://www.valueinhealthjournal.com/article/S1098-3015(12)02658-7/fulltext
Title :
PCV2 Comparative Efficacy and Safety Analysis of Atrial Fibrillaion Patients Treated with Dabigatran in RE-LY Study (CHADS 2 Score of 3 or Greater ) Versus Rivaroxaban in ROCKET-AF
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02658-7&doi=10.1016/j.jval.2012.08.945
First page :
A362
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
453